Study: Pfizer’s Paxlovid Can Lower Post-COVID Symptoms
Pfizer Inc.’s Paxlovid antiviral that lowers rates of illness and death in people infected with COVID-19 also reduces the risk of some symptoms of long-COVID, a study found. According to the study, taking Paxlovid within five days of testing positive for COVID-19 infection was linked to a 26 percent lower risk of post-viral complications. This […]
Continue Reading